Phase I-II trial of VM-26 (NSC-122819) in the treatment of children with late-stage leukemia.
D000208:Acute Disease; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D006412:Hematopoietic Stem Cells; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D007958:Leukocyte Count; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013713:Teniposide / Q000627:therapeutic use* / Q000633:toxicity
D013713:Teniposide; D011034:Podophyllotoxin